Los Alamos, NM, United States of America

Erick LeBrun

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Erick LeBrun

Introduction

Erick LeBrun is an accomplished inventor based in Los Alamos, NM (US). He has made significant contributions to the field of cannabinoid research, particularly through his innovative patent work. His expertise and dedication to advancing cannabinoid science have positioned him as a notable figure in the industry.

Latest Patents

Erick LeBrun holds a patent titled "Systems, methods, and compositions for the glycosylation of cannabinoid compounds." This invention relates to the identification of novel UDP-glucosyltransferases enzymes that exhibit specific activity towards cannabinoid compounds. The patent further explores the use of these novel UGT enzymes to generate water-soluble cannabinoid glycoside compounds. This innovation has the potential to enhance the bioavailability and therapeutic applications of cannabinoids.

Career Highlights

LeBrun's career is marked by his role at Trait Biosciences, Inc., where he continues to push the boundaries of cannabinoid research. His work focuses on developing methods that improve the efficacy and usability of cannabinoid compounds in various applications. With a patent portfolio that includes 1 patent, he demonstrates a commitment to innovation in this rapidly evolving field.

Collaborations

Erick collaborates with Timothy Travers, leveraging their combined expertise to further advance their research initiatives. Their partnership exemplifies the collaborative spirit that drives innovation in the scientific community.

Conclusion

Erick LeBrun's contributions to cannabinoid research through his innovative patent work highlight his role as a leading inventor in the field. His dedication to developing new methods and compositions continues to pave the way for advancements in cannabinoid applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…